Investigation of Bone Defects and Microcirculation With Computed Tomography and Magnetic Resonance Imaging
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01374412|
Recruitment Status : Recruiting
First Posted : June 16, 2011
Last Update Posted : December 7, 2016
Subject of the proposed study is the non-invasive in vivo imaging of bone, bone marrow and localized microcirculation in test animals with osteoporosis, fractures and after placement of bone substitute material with volume computed tomography (VCT) (animals only) and functional magnetic resonance imaging (MRI). Furthermore patients with multiple myeloma (MM) will be examined before and after placement of a commercially available bone substitute material. Osseous structures before intervention and structural changes of the bone especially at the junction of substitute material and residual bone will be documented. At this, the proposed techniques allow imaging of the dynamic healing processes in the living organism.
As next step patients with asymptomatic MM will be investigated with functional Imaging longitudinally to predict the occurence of osteolyses at time of Progression.
Hypothesis: Affection of microcirculation at the junction of bone and bone substitute material can be displayed by VCT and functional MRI
|Condition or disease|
|Osteoporosis Multiple Myeloma Vertebral Fracture|
In 157 patients with asymptomatic MM dynamic contrast-enhanced MRI (DCE-MRI) and diffusion weighted imaging (DWI) of the vertebral column will be performed every 6 months until progression and/ or occurance of first osteolysis.
In an experimental study, mice, rats and sheep with and without an osteoporotic phenotype will be imaged with VCT, morphologic MRI, DCE-MRI and DWI. Using these methods, bone structure, vascularization and cellularity will be assessed in control and osteoporotic animals. Furthermore, these morphological and functional imaging techniques will be applied before and after implantation of biomaterials in bone in order to characterize morphological and functional changes in bone upon implantation of these biomaterials.
|Study Type :||Observational|
|Estimated Enrollment :||60 participants|
|Official Title:||Examination of Bone Defects and Microcirculation Using Volume Computed Tomography and Dynamic Contrast-enhanced Magnetic Resonance Imaging|
|Study Start Date :||July 2010|
|Estimated Primary Completion Date :||July 2018|
|Estimated Study Completion Date :||July 2022|
patients with benign osteoporosis
- Changes of microcirculation at the interface between bone and implanted xenomaterial in patients with osteoporosis or multiple myeloma [ Time Frame: before (baseline)and after intervention, in follow-up 2 weeks, 1 month, 4 months after intervention ]This is a study within a multicenter multiproject frame. Development of bone-stabilizing implant material designed to stimulate the formation and regeneration of physiologically structured bone after vertebral collapse will be investigated. The subproject examins the interaction between host and graft. Hypothesis: Implanted materials will function as a framework for osteogenesis, and successful integration of the foreign material goes along with transient increase in microcirculation. Amplitude A and exchange rate constant kep of DCE-MRI will be measured to detect changes in microcirculation.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01374412
|Contact: Stefan Delorme, MDfirstname.lastname@example.org|
|German Cancer Research Center||Recruiting|
|Heidelberg, Germany, 69120|
|Study Chair:||Reinhard Schnettler, MD||Gießen University, Heidelberg|